All lobbying filings

Myriad Genetics, Inc.

Myriad Genetics, Inc. filed a Q1 report for Myriad Genetics, Inc. on April 20, 2026.

Lobbying for Myriad Genetics, Inc.

As filed: MYRIAD GENETICS, INC. for MYRIAD GENETICS, INC.

All filings by Myriad Genetics, Inc. · Everything Myriad Genetics, Inc. has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Expenses

$260,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Medicare/Medicaid

Prior authorization issues in Medicare Advantage.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.